Stock Analiz

REGENXBIO Inc. (RGNX) stock forecast and price target

Price $7.64 · data as of November 13, 2026

12-month price target

Average target$21.40
Upside / downside+180.1%
Analysts10
ConsensusStrong buy
Low $12.00Average $21.40High $42.00

Gold marker: average target · white marker: today’s price ($7.64)

Analyst ratings

Strong buy 3Buy 7Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-3.58+4.9%$160M
Next fiscal year
ends December 31, 2027
$-3.28+8.2%$198M
Next quarter
ends December 31, 2026
$-1.49−14.4%$9M
Quarter after
ends March 31, 2027
$-0.99+42.4%$9M

Consensus of the analysts covering REGENXBIO, updated daily. In the last 30 days 2 estimates were raised and 1 lowered.

Frequently asked questions

What is the REGENXBIO stock price target?

The average 12-month target from 10 analysts is $21.40, 180.1% above the current price of $7.64 Targets range from $12.00 to $42.00.

Is REGENXBIO a buy according to analysts?

The consensus rating is “Strong buy” (3 strong buy, 7 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is REGENXBIO expected to earn?

Analysts expect EPS of $-3.58 for the fiscal year ending December 31, 2026 and $-3.28 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.